Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.

McMahon B, Block J, Block T, Cohen C, Evans AA, Hosangadi A, London WT, Sherman M; 2015 Princeton HCC Workshop participants..

J Natl Cancer Inst. 2015 Nov 30;108(4). pii: djv359. doi: 10.1093/jnci/djv359.

PMID:
26626106
2.
3.

Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.

Hu B, Tian X, Sun J, Meng X.

Int J Mol Sci. 2013 Dec 2;14(12):23559-80. doi: 10.3390/ijms141223559.

4.

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring.

Wang L, Yao M, Dong Z, Zhang Y, Yao D.

Tumour Biol. 2014 Jan;35(1):9-20. doi: 10.1007/s13277-013-1141-0. Review.

5.

The growing epidemic of hepatocellular carcinoma.

Marrero JB.

Gastroenterol Hepatol (N Y). 2008 Nov;4(11):779-80. No abstract available.

6.

Proteomic analysis for developing new biomarkers of hepatocellular carcinoma.

Pleguezuelo M, Lopez-Sanchez LM, Rodriguez-Ariza A, Montero JL, Briceno J, Ciria R, Muntane J, de la Mata M.

World J Hepatol. 2010 Mar 27;2(3):127-35. doi: 10.4254/wjh.v2.i3.127.

7.

Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Andreana L, Isgrò G, Pleguezuelo M, Germani G, Burroughs AK.

World J Hepatol. 2009 Oct 31;1(1):48-61. doi: 10.4254/wjh.v1.i1.48.

8.

Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma.

Liu H, Li P, Zhai Y, Qu CF, Zhang LJ, Tan YF, Li N, Ding HG.

World J Gastroenterol. 2010 Sep 21;16(35):4410-5.

9.
Items per page

Supplemental Content

Support Center